APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

25 hedge funds and large institutions have $3.25M invested in Aptose Biosciences, Inc. in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$454K
2
Citadel Advisors
2
Citadel Advisors
Florida
$155K
3
TSS
3
Two Sigma Securities
New York
$39.3K
4
TCBWMS
4
Texas Capital Bank Wealth Management Services
Texas
$31.6K
5
CA
5
Cetera Advisors
Colorado
$61.1K

Top Sellers

1
SPC
1
Sigma Planning Corp
Michigan
$192K
2
NCM
2
Nantahala Capital Management
Connecticut
$305K
3
CC
3
Carlson Capital
Texas
$246K
4
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
$0
5
Bank of America
5
Bank of America
North Carolina
$254
Name Holding Trade Value Shares
Change 		Shares
Change %
National Bank of Canada
26
National Bank of Canada
Quebec, Canada
$33 -$3 – –
PCWA
27
Pacific Capital Wealth Advisors
California
$15 – – –
Fidelity International
28
Fidelity International
Bermuda
$3 -$4 – –
Citigroup
29
Citigroup
New York
$3 – – –
Toronto Dominion Bank
30
Toronto Dominion Bank
Ontario, Canada
– -$12.9K -153 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$526 -6 Closed
1
2